The Mental Health
Market Today

The lifetime prevalence in Canada and the United States of PTSD is between 9%-10 %

A recent study has found that in patients with no previous psychiatric history, a diagnosis of COVID-19 was associated with increased incidence of a first psychiatric diagnosis in the following 14 to 90 days compared with

six other health events.

The need for mental health treatment has skyrocketed in the last 12 months.

Treating conditions such

as depression, PTSD and

anxiety just to name a few

is becoming critical 

in our communities.

Mental Health Spending in Canada: $4.7B annually within healthcare;

$6.3B on uninsured mental health services and time off for depression/anxiety.

However, treatments for many patients are not successful and/or

available medications have too many side effects.


Click above for Fast Facts about Mental Illness

The growth of the behavioral health treatment market globally
is expected to reach

$240 billion by 2026.

Of this, the current estimated psychedelic market value is approximately $100 billion

Company Insights

PsiloTec tracks 17 publicly listed companies in this space which are

listed on various stock exchanges; however, none have a similar

focus on organic therapy mushrooms and e-Clinics.